Abstract
Classic and overlapping Miller-Fisher syndrome (MFS) have divergent clinical courses. Few studies have addressed the electrophysiological evaluation of MFS patients, most of them carried out in Asia. This work describes and compares their clinical and neurophysiological characteristics. From a Guillain-Barré syndrome (GBS) patient cohort, we made a selection of twenty MFS cases. We defined classic and overlapping MFS, as stated by Wakerley et al. (Nat Rev Neurol 10(9):537–544, 2014). We describe and compare clinical, biochemical, and electrodiagnostic parameters between groups. Seventy-five percent were men, mean age was 42.2 ± 13.6 years, and 45% had a Hughes score ≥ 3. MFS/GBS was the most frequent clinical subtype with 50%. Almost one-third had unaltered electrophysiological studies. Comparative analysis between groups showed statistically significant differences in length of stay, dysautonomia presence, and treatment type. Kaplan-Meier survival analysis showed that 100% of the patients had an independent walk at 3 months. This study reports Mexican MFS patient’s characteristics and represents the most extensive case series in Latin America. We observed a high proportion of overlapping syndromes, a good recovery profile, and no significant severe complications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Doets AY, Verboon C, Van de Berg B, Harbo T, Cornblath DR, Willison HJ et al (2018) IGOS Consortium Regional variation of Guillain-Barré syndrome. Brain 141(10):2866–2877. https://doi.org/10.1093/brain/awy232
Ishii J, Yuki N, Kawamoto M, Yoshimura H, Kusonoki S, Kohara N (2016) Recurrent Guillain-Barré syndrome, Miller Fisher syndrome and Bickerstaff brainstem encephalitis. J Neurol Sci 364:59–64. https://doi.org/10.1016/j.jns.2016.03.008
Gómez A, Diaz A, Carrión-Penagos J, Reyes J, Reyes S (2019) Clinical electrophysiological characteristics of Guillain-Barré syndrome in Colombia. J Peripher Nerv Syst 24(3):268–271. https://doi.org/10.1111/jns.12340
Wakerley BR, Uncini A, Yuki N (2014) GBS Classification Group. Guillain-Barré and Miller Fisher syndromes—new diagnostic classification. Nat Rev Neurol 10(9):537–544. https://doi.org/10.1038/nrneurol.2014.138
Fisher CM (1956) An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 255:57–65. https://doi.org/10.1056/NEJM195607122550201
Mori M, Kuwabara S, Yuki N (2012) Fisher syndrome: clinical features, immnopathogenesis and management. Expert Rev Neurother 12(1):39–51. https://doi.org/10.1586/ern.11.182
Shahrizaila N, Yuki N (2013) Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1B antibody syndrome. J Neurol Neurosurg Psychiatry 84(5):576–583. https://doi.org/10.1136/jnnp-2012-302824
Sekiguchi Y, Mori M, Misawa S, Sawai S, Yuki N, Beppu M, Kuwabara S (2016) How often and when Fisher syndrome is overlapped by Guillain-Barre syndrome or Bickerstaff brainstem encephalitis? Eur J Neurol 23(6):1058–1063. https://doi.org/10.1111/ene.12983
Wakerley BR, Yuki N (2014) Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome. J Neurol Neurosurg Psichiatry 85(3):339–344. https://doi.org/10.1136/jnnp-2013-305397
Hu Q, Li H, Tian J, Zhang B (2018) Bulbar paralysis associated with Miller-Fisher syndrome and its overlaps in Chinese patients. Neurol Sci 39(2):305–311. https://doi.org/10.1007/s10072-017-3184-2
Arányi Z, Kovács T, Sipos I, Bereczki D (2012) Miller Fisher syndrome: brief overview and update with a focus on electrophysiological findings. Eur Neurol 19(1):15–20. https://doi.org/10.1111/j.1468-1331.2011.03445.x
Verboon C, van Berghem H, van Doom PA, Ruts L, Jacobs BC (2017) Prediction of disease progression in Miller Fisher and overlap syndromes. J Peripher Nerv Syst 22(4):446–450. https://doi.org/10.1111/jns.12238
Yuan CL, Wang YJ, Tsai CP (2000) Miller Fisher syndrome: a hospital -based retrospective study. Eur Neurol 44(2):79–85. https://doi.org/10.1159/000008201
San-Juan OD, Martinez-Herrera JF, García JM, Gonzalez-Aragon MF, Del Castillo-Calcáneo JD, Pérez-Neri I (2009) Miller Fisher syndrome: 10 years’ experience in a third-level center. Eur Neurol 62(3):149–154. https://doi.org/10.1159/000226599
Jung JH, Oh EH, Shin JH, Kim DS, Choi SY, Choi KD, Choi JH (2019) Atypical clinical manifestations of Miller Fisher syndrome. Neurol Sci 40(1):67–73. https://doi.org/10.1007/s10072-018-3580-2
Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T (2001) Clinical features and prognosis of Miller Fisher syndrome. Neurology 56(8):1104–1106. https://doi.org/10.1212/wnl.56.8.1104.8
Walgaarr C, Lingsma HFM, Ruts L, van Doorn PA, Steyerberg EW, Jacobs BC (2011) Early recognition of poor prognosis in Guillan-Barre syndrome. Neurology 76(11):968–975. https://doi.org/10.1212/WNL.0b013e3182104407
Lo YL (2007) Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 36(5):615–627. https://doi.org/10.1002/mus.20835
Alam A, Puri NV (2014) Inefficacy of antipsychotic in treatment of delirium and agitation in two cases of Bickerstaff brainstem encephalitis. J Neuropsychiatr Clin Neurosci 26(2):176–178. https://doi.org/10.1176/appi.neuropsych.13040078
Uchigami H, Saito Y, Tsuchida T, Uchibori A, Chiba A, Saito M (2020) Comparison of antibody reactivity in the first and second episodes of recurrent Miller Fisher syndrome. Neurol Sci. https://doi.org/10.1007/s10072-020-04850-3
Barbato F, Di Paolantonio A, Distefano M, Mastrorosa A, Sabatelli M, Servidei S, Luigetti M (2017) Recurrent Miller Fisher: a new case report and a literature review. Clin Ter 168(3):e208–e213. https://doi.org/10.7417/T.2017.2008
Alberti MA, Povedano M, Monero J, Casasnovas C (2020) Early electrophysiological findings in Fisher-Bickerstaff syndrome. Neurologia 35(1):40–45. https://doi.org/10.1016/j.nrl.2017.05.012
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by López-Hernández Juan Carlos, Bazán-Rodríguez Lisette, Vargas-Cañas Steven, and Jorge de Saráchaga Adib. The first draft of the manuscript was written by Bazán-Rodríguez Lisette and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Conceptualization: Jorge de Saráchaga Adib; methodology: López-Hernández Juan Carlos; formal analysis and investigation: León-Manriquez Elizabeth, Briseño-Godinez Maria Eugenia; writing - original draft preparation: Vargas-Cañas Steven; writing - review and editing: Bazán-Rodríguez Lisette; resources: Pérez-Valdez Esther Y, Pérez-Jovel Enrique; supervision: Briseño-Godinez Maria Eugenia, May-Mas Raúl.
This statement indicates that all authors’ agreement about the above information is true and correct.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All subjects gave written informed consent to participate in the study. The study protocol was approved by the local Ethics Committee.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bazán-Rodríguez, L., López-Hernández, J.C., Jorge de Saráchaga, A. et al. Classic and overlapping Miller-Fisher syndrome: clinical and electrophysiological features in Mexican adults. Neurol Sci 42, 4225–4229 (2021). https://doi.org/10.1007/s10072-020-05029-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-05029-6